Systemic scleroderma

Results: 82



#Item
1PRESS RELEASE Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading de

PRESS RELEASE Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading de

Add to Reading List

Source URL: www.biomedvc.com

Language: English - Date: 2015-11-12 02:47:43
2Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29.

Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29.

Add to Reading List

Source URL: www.switt.ch

Language: English - Date: 2014-02-01 16:20:50
3Curriculum Vitae BIOGRAPHICAL Name: Janet L. Poole Birthplace: La Jolla, CA Citizenship: USA Business Address:

Curriculum Vitae BIOGRAPHICAL Name: Janet L. Poole Birthplace: La Jolla, CA Citizenship: USA Business Address:

Add to Reading List

Source URL: ot.unm.edu

Language: English - Date: 2015-02-12 12:50:15
4Soluble CD90 as biomarker of pulmonary complications in Systemic Sclerosis A new serological two-staged biomarker of pulmonaryarterial hypertension and pulmonary fibrosis Subtitle Technology

Soluble CD90 as biomarker of pulmonary complications in Systemic Sclerosis A new serological two-staged biomarker of pulmonaryarterial hypertension and pulmonary fibrosis Subtitle Technology

Add to Reading List

Source URL: www.campus-technologies.de

Language: English - Date: 2015-02-19 09:34:47
5ARTHRITIS INFORMATION SHEET Scleroderma This sheet has been written for people affected by scleroderma. It provides general

ARTHRITIS INFORMATION SHEET Scleroderma This sheet has been written for people affected by scleroderma. It provides general

Add to Reading List

Source URL: www.arthritiswa.org.au

Language: English - Date: 2012-04-09 23:00:14
6Available online http://arthritis-research.com/content/9/S2/S6 Review Therapeutic targets in systemic sclerosis Christopher P Denton

Available online http://arthritis-research.com/content/9/S2/S6 Review Therapeutic targets in systemic sclerosis Christopher P Denton

Add to Reading List

Source URL: arthritis-research.com

Language: English
7Clinical Commissioning Policy: Sildenafil and bosentan for the treatment of digital ulceration in systemic sclerosis Reference: NHS England A13/P/e

Clinical Commissioning Policy: Sildenafil and bosentan for the treatment of digital ulceration in systemic sclerosis Reference: NHS England A13/P/e

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2015-01-30 12:35:16
8CLINICAL Antinuclear antibody test Michael O’Sullivan Andrew McLean-Tooke Richard Loh

CLINICAL Antinuclear antibody test Michael O’Sullivan Andrew McLean-Tooke Richard Loh

Add to Reading List

Source URL: www.racgp.org.au

Language: English - Date: 2013-09-26 00:20:12
9ARTHRITIS INFORMATION SHEET ARTHRITIS

ARTHRITIS INFORMATION SHEET ARTHRITIS

Add to Reading List

Source URL: www.arthritisaustralia.com.au

Language: English - Date: 2015-03-12 23:37:49
10Erythrocyte glutathione transferase: a non-antibody biomarker for systemic sclerosis, which correlates with severity and activity of the disease

Erythrocyte glutathione transferase: a non-antibody biomarker for systemic sclerosis, which correlates with severity and activity of the disease

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-07-25 09:54:49